Interpace Biosciences (IDXG) Reports Q3 EPS of $0.31

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.31. Revenue for the quarter came in at $12.3 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity